
Reset all filters
01 4Astrazeneca Ab
02 2Astrazeneca Ag
Reset all filters
01 4Acalabrutinib
02 1Acalabrutinib Maleate
03 1Acalabrutinib Maleate Monohydrate
Reset all filters
01 1Capsule
02 3Film Coated Tablet
03 2Hard Capsule
Reset all filters
01 2Spain
02 2Sweden
03 2Switzerland
Reset all filters
01 6Calquence
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Calquence
Dosage Form : Capsule
Dosage Strength : 100mg
Packaging :
Approval Date : 2020-11-05
Application Number : 20191015000025
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Calquence
Dosage Form : Hard Capsule
Dosage Strength : 100mg
Packaging :
Approval Date : 2021-03-04
Application Number : 67790
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Calquence
Dosage Form : Film Coated Tablet
Dosage Strength : 100mg
Packaging :
Approval Date : 2023-05-04
Application Number : 68817
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Approved
Registration Country : Sweden
Acalabrutinib Maleate Monohydrate
Brand Name : Calquence
Dosage Form : Film Coated Tablet
Dosage Strength : 100mg
Packaging :
Approval Date : 2023-02-20
Application Number : 20211012000078
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Calquence
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG
Packaging :
Approval Date : 2023-06-21
Application Number : 1201479004
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Calquence
Dosage Form : Hard Capsule
Dosage Strength : 100MG
Packaging :
Approval Date : 2020-11-18
Application Number : 1201479002
Regulatory Info : Authorized
Registration Country : Spain